Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))
NCT01163292
·
clinicaltrials.gov ↗
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Sponsor
AbbVie (prior sponsor, Abbott)